Nav1.7 inhibitor blocks sodium channels, affecting the action potential propagation in neurons and muscle cells, crucial for neurological and muscular function.
Molecular Weight
426.67
Molecular Formula
C15H11Cl3FNO4S
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
Nav1.7 inhibitor is studied for its promise in treating chronic pain by targeting sodium channels involved in nociceptive signaling.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
